[144] Savers Value Village, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Savers Value Village, Inc. (SVV) reports a proposed sale of 20,000 common shares through Fidelity Brokerage on 09/26/2025 with an aggregate market value of $273,809.37. The shares were recorded as acquired on 09/26/2025 via an option originally granted on 06/12/2019, with payment in cash. The filing lists 155,555,984 shares outstanding. The document also discloses multiple prior insider sales by Richard Medway between 07/03/2025 and 09/24/2025. The filer certifies no undisclosed material adverse information.

Positive

• Clear Rule 144 disclosure of the proposed sale including broker, date, and aggregate market value
• Acquisition details provided (option grant date 06/12/2019 and exercise/payment in cash on 09/26/2025), clarifying the transaction basis

Negative

• Substantial insider selling by Richard Medway across July–September 2025 as listed, which may concern some investors
• Large outstanding share count disclosed (155,555,984), meaning the 20,000-share sale is a small portion but prior sales are numerous

Insights

Securities Analyst

TL;DR: Insider plans to sell 20,000 shares following option exercise; recent sales by the same insider are sizable and should be noted.

The Form 144 documents a routine Rule 144 notice for a proposed sale of 20,000 common shares valued at $273,809.37, executed through Fidelity on 09/26/2025 after an option grant dated 06/12/2019. The filing provides required transparency for an insider liquidity event and discloses an outstanding share base of 155,555,984. The schedule of prior sales by Richard Medway shows repeated dispositions across July–September 2025, which investors and analysts commonly review for potential signaling, concentration of supply, and timing relative to company disclosures.

Corporate Governance Expert

TL;DR: Proper Rule 144 disclosure appears made; recurring insider sales warrant attention from governance and compliance perspectives.

The notice fulfills procedural requirements by identifying the broker, date of proposed sale, acquisition method (option exercise), and certification regarding material nonpublic information. The repeated sales by the named insider over the prior three months are explicitly listed, which is important for governance oversight and insider trading compliance reviews. Documentation of exercise date and cash payment clarifies the transaction mechanics for audit and disclosure purposes.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	20000	273809.37	155555984	09/26/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/26/2025	Option Granted - 06/12/2019	Issuer			20000	09/26/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	07/03/2025	17619	187642.35
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	07/18/2025	1800	18950.94
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	07/22/2025	600	6306.00
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	07/23/2025	4228	44415.99
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	07/31/2025	2637	27641.56
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	08/01/2025	45735	505108.16
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	08/04/2025	15000	172200.00
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	08/29/2025	15000	179700.00
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	09/02/2025	17500	218912.75
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	09/05/2025	2300	29900.46
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	09/11/2025	1333	17363.79
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	09/17/2025	3615	46931.74
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	09/18/2025	1200	15582.48
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	09/24/2025	9052	118051.66

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for SVV disclose about the proposed sale?

It discloses a proposed sale of 20,000 common shares through Fidelity on 09/26/2025 with aggregate market value $273,809.37.

How were the 20,000 SVV shares acquired?

The shares were recorded as acquired on 09/26/2025 via an option granted on 06/12/2019, with payment made in cash.

Who is the insider with prior sales listed in the filing?

The filing lists prior sales by Richard Medway with multiple dispositions between 07/03/2025 and 09/24/2025.

How many shares outstanding does the filing report for SVV?

The filing reports 155,555,984 shares outstanding.

Does the filer certify there is no undisclosed material information?

Yes, the person for whose account the securities will be sold represents by signing the notice that they do not know any material adverse information that has not been publicly disclosed.